Officials carry out raids near Bengaluru that uncover an alleged counterfeit and spurious medicines operation, with authorities reportedly seizing products worth more than Rs 5 crore.
The action targets an unlicensed manufacturing unit, where officials say fake or substandard medicines were being produced and stored for supply. Authorities describe the seized items as intended for use in healthcare settings, including ICUs, though details on the full distribution network and end-use are not fully consistent across reporting.
Across coverage, the focus remains on the size of the seizure and the alleged breach of licensing and manufacturing norms. Outlets also differ in how they frame the scope of the racket—some emphasizing the unlicensed unit itself, while others highlight the potential risk to hospital patients if such products reach wards or critical care areas. Investigations into those involved, including any possible links to suppliers and distributors, are ongoing.
